HySigen Biosciences is a prominent global biotechnology enterprise that integrates R&D, services, and products, specializing in gene editing in cell lines and animal models. HySigen Biosciences embodies a pioneering force in the field of life sciences. Leveraging its profound technological expertise, HySigen Biosciences is devoted to providing exceptional gene editing services to a broad clientele. Our valued customers range across basic research, drug development and translational medicine.